Adverse drug events happen all too often in older adults , but we still do not have a clear understanding of potentially modifiable risk factors , with the exception of polypharmacy. This paper critiques the article in this issue of The Annals entitled, "Inappropriate Prescribing Pred icts Adverse Drug Events in Older Ad ults ." A validated measure for self-reported adverse drug events was used , along with a mod ified measure for inappropriate prescribing that we developed nearly 2 decades ago (ie, Med ication Appropriateness Index). Bes ides discussing the strengths and wea knesses of this article, we also recommend future research directions in this area.
See also page 957.
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I n this issue of The Annals is an important article that examines the predictive validity of both an explicit and implicit method to relate inappropriate prescribing with adverse drug events (ADEs) in older adults.' This study is importantfor several reasons; one is that there are limited data regarding self-reported ADEs in elderly community-dwelling or outpatientclinicpopulations, with yearly rates ranging from 10% to 35%.2-6 The authors found a self-reported ADE rate of 14% in 240 older outpatient veterans, which is consistent with these previous studies.' The accuracy of thisfinding would be improved if the self-reported ADEs were matched to medical record documentation of ADEs, if 2 clinical pharmacists ratedthe ADEs and measured their agreement, and if the pharmacists used a standardized causality algorithm. Even so, one wonders whether this single question should become a routine part of ambulatory care practice, given that the question is easy to use, reliable, and valid."
The second reason this study is important is that few studies have examined the association between explicit measures of inappropriate prescribing and ADEs.6,9 In the Lund et al. study, the point estimate for the risk of exposure to inappropriate drugs as measured by the 2003 Beers criteriafor drugs with an ADE was 1.43,but thisodds ratio was not statistically significant.I We agree with the authors' assessment that this could be due to insufficient power.It is importantto note that a recent study by one of the article's authors found a point estimate for the risk of exposure to inappropriate drugs as measured by explicit we and other investigators have confirmed that the MAl has good reliability and face validity and is responsiveto changeovertimein health services intervention trials," Prior to the Lund et al. study, the only predictive validity testing donewith theMAl wasa simple bivariate analysis published in The Annals over a decadeago showingassociations betweenworse MAl scores and poorerbloodpressure control and useof morehealth services," One mightask whyit has taken so longto examine this issue further. As noted by Lund et al., the MAl, while comprehensive, is burdensome, as it can take up to 10minutes per drug to apply the instrument andit requires a well-trained health professional.
So, what studies are neededto furtherassessthe predictive validity of this implicitmeasureof inappropriate prescribing? One approachis to test the relationship between the modified MAl as described in the current study and ADEs in largerpopulation samples other than veterans. In addition, studies using larger samples that include older womencould determine whetherdrug-drugand drug-disease interactions that received the largest weights are associated with the greatest risk of ADEs. Finally,the current version of the MAl (last updated in 2010) accounts for over-and underdosing separately. It wouldbe of interest to see whether over-and underdosing, respectively, predict ADEs and therapeutic failure.
The determination of risk for ADEs by measures of inappropriate prescribing is not an easy task. Lund et al. are to be commended for adding to our knowledge of thiscritically important area of geriatric pharmacotherapy.
